The K7 Is Changing the Economics of Security
$65-an-hour guards can't compete with a $15-an-hour AI machine that never sleeps. The K7 delivers nonstop protection and smarter analytics that improve with every patrol.
These are the 37 donors helping pay for Trump's $300 million White House ballroom
WASHINGTON (AP) — President Donald Trump says his $300 million White House ballroom will be paid for “100% by me and some friends of mine.”
Gilead's One-Pill HIV Treatment Shows Promise In Late-Stage Trial
Gilead's Phase 3 ARTISTRY-1 trial shows its single-tablet HIV regimen of bictegravir and lenacapavir matches the efficacy and safety of current therapy.
Trump Signs Law to Launch Dollar 2.0 - Ad
Trump just signed law S.1582, unleashing the biggest money shift in 100+ years. For the first time since 1913, private firms - not the Fed - can mint a "Dollar 2.0." Treasury says it could drain $6.6T from banks and pay 10X current savings rates. Early investors in minting firms could see 40X returns by 2032.
FDA says drugmakers have recalled a blood pressure medicine tainted with a cancer-causing chemical
The U.S. Food and Drug Administration says drugmakers have recalled more than a half-million bottles of the blood pressure medication prazosin hydrochloride over concerns it may include a cancer-causing chemical.
Obesity, diabetes treatments fuel Eli Lilly growth and spark bidding war
The market for obesity and diabetes treatments remains scorching hot, funneling billions in sales to Eli Lilly and fueling a bidding war over another drugmaker.
"Tech Prophet" Who Predicted the iPhone Now Predicts... - Ad
George Gilder - who predicted the iPhone 17 years early and gave Reagan the first microchip - is making his boldest call yet. He says an American nanotech "super-convergence" could mint more millionaires than any event in recent memory. He's found 3 stocks set to benefit before November 18's bombshell.
Some Head Start preschools shutter as government shutdown continues
The government shutdown is triggering a wave of closures of , leaving working parents scrambling for child care and shutting some of the nation's neediest children out of preschool.
CVS Health tops Q3 forecasts but absorbs hefty charge for struggling clinic business
CVS Health rode double-digit sales growth from drugstores and its pharmacy benefits management business to a better-than-expected third quarter.
The Tesla Shock Nobody Sees Coming - Ad
While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as January 29.
Applied Therapeutics Tanks As FDA Path For Lead Rare-Disease Drug Turns Uncertain
Applied Therapeutics stock falls after FDA feedback prompts another Type C meeting to discuss the Phase 3 plan for its CMT-SORD drug govorestat.
Workers take on side jobs to combat stagnant salaries and insecurity about employment
NEW YORK (AP) — As workers face , inflation and , some have decided to branch out from their traditional careers. They're taking on side jobs to bring in additional income and provide a backup plan should they , or adding second, third and sometimes fourth jobs — what some call “polyworking” — to the mix.
[Revealed] The $100 Starlink Pre-IPO Blueprint! - Ad
Fortune reports Starlink's rumored IPO is set to be the single largest IPO in history. James Altucher has uncovered a way to get a pre-IPO stake BEFORE Starlink goes public. All it takes is just a few minutes of time and as little as $100 to get started.
A flotilla kicks off the People's Summit for activists at UN climate talks
BELEM, Brazil (AP) — As United Nations climate talks rolled on Wednesday at the elaborate new venues built for the summit, many of the activists eager to shape the talks took to the water.
More than 80 nonprofits receive $250M for global women's health from Melinda French Gates
More than 80 organizations that provide health care for women all over the world received grants Wednesday totaling after a year-long application process.
America's Next Security Revolution Has Begun - Ad
Built for endurance, powered by AI, and proven in the field, the K7 is redefining protection for ports, energy hubs, and cities across the nation. The rollout is already underway.
FDA names longtime cancer scientist Pazdur to lead drug center
WASHINGTON (AP) — The Food and Drug Administration on Tuesday named a longtime regulator of cancer medicines to lead the agency's drug center, replacing the who was recently ousted after an .
Analyst Sees Strong Medtronic Momentum Through 2026 With Buy Rating Intact
BofA expects Medtronic to post over 5% second-quarter revenue growth and maintain strong momentum through 2026, driven by robust procedure trends.
The K7 Is Changing the Economics of Security - Ad
$65-an-hour guards can't compete with a $15-an-hour AI machine that never sleeps. The K7 delivers nonstop protection and smarter analytics that improve with every patrol.
A deal to end the government shutdown is on track but faces hurdles
WASHINGTON (AP) — A legislative package to end appears on track Monday after a handful of Senate Democrats joined with Republicans to break the impasse in what has become of federal , the longest in history.
You're Almost Out of Time to Place This "Debasement Trade" - Ad
Wall Street has been making headlines for piling into a strange new money move they're calling the "Debasement Trade"... And it could affect you and your money in a MAJOR way. According to Dr. David Eifrig the clock is ticking for you to get your money in the right place.
What to know about COP30, this year's UN climate talks
People from around the world are beginning to gather at the gateway of the Amazon in Belem, Brazil, for the 30th annual United Nations climate summit, the Conference of the Parties, known less formally as COP30.
Eledon Pharmaceuticals' Lead Asset Fails In Mid-Stage Study, But Pushes Forward With Pivotal Study
Eledon shares drop as tegoprubart misses the main goal in Phase 2 kidney transplant trial, though safety signals and kidney function data remain encouraging.
Another Gold High? Here's the Move Wall Street Is Missing ... - Ad
Gold just surged past $4,200, up 45% in a year - but Sean Brodrick says $6,900 could be next. History shows when gold booms, one hidden play has delivered far bigger gains - 21x, 49x, even 1,386x. The same strategy once handed 26,000% profits. And Sean says it's back on the table now.
Deep in Trump country, coal miners with black lung say government is suffocating the 'working man'
OAK HILL, W.Va. (AP) — Lisa Emery loves to talk about her “boys.” With each word, the respiratory therapist’s face softens and shines with pride. But keep her talking, and it doesn’t take long for that passion to switch to hurt. She knows the names, ages, families and the intimate stories of each one’s scarred lungs. She worries about a whole community of West Virginia coal miners — including a growing number in their 30s and 40s — who come to her for help while getting sicker and sicker from what used to be considered an old-timer’s disease: black lung.
Oscar Health Misses Q3 Revenue, Loss Widens To $129 Million Despite Membership Surge
Oscar Health's Q3 revenue rose to $2.99 billion on higher membership, but losses widened as risk adjustments offset gains.
AI Meets Real-World Security with the K7 - Ad
Continuous patrols. Instant response. Zero fatigue. The K7 merges robotics and data to outperform humans in coverage, cost, and consistency and it's already live across the US.
FDA warns websites selling unapproved Botox for cosmetic purposes
Associated Press (AP) — U.S. health regulators on Wednesday sent warning letters to 18 websites selling and similar injectable drugs commonly used to smooth wrinkles.
Analysts Lower Cigna Targets As PBM Segment Guidance Surprises Market
Cigna expects 2026–2027 margin pressure from its new rebate-free PBM model as major clients renew at lower margins, prompting analyst target cuts.
After 50 Years of Chemo, One Biotech Could Lead the Next Cancer Breakthrough - Ad
For decades, toxic chemotherapy defined cancer care. This biotech's innovative approach could finally change that. With early results showing precision without poison, this story is one investors will want to see early.
Alvotech Shares Plunge 33% After FDA Flags Issues
Alvotech shares decline after the FDA issues a complete response letter for its Simponi biosimilar, leading to a lower 2025 revenue and EBITDA outlook.
Kimberly-Clark buying Tylenol maker Kenvue in $48.7 billion deal
Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company.
Trump Signs Law to Launch Dollar 2.0 - Ad
Trump just signed law S.1582, unleashing the biggest money shift in 100+ years. For the first time since 1913, private firms - not the Fed - can mint a "Dollar 2.0." Treasury says it could drain $6.6T from banks and pay 10X current savings rates. Early investors in minting firms could see 40X returns by 2032.
Hakeem Jeffries, Chuck Schumer Blast Trump's White House Bathroom Makeover: 'Millions Of Americans Will Face...Quadruple Health Insurance Premiums'
Democrats blasted President Trump's focus on a White House bathroom renovation while millions of Americans brace for soaring health insurance premiums.
Super greens powder supplements sold at Sam's Club linked to salmonella outbreak
At least 11 people have been sickened, including three who were hospitalized, with linked to sold at nationwide and online, federal health officials said Friday.
"Tech Prophet" Who Predicted the iPhone Now Predicts... - Ad
George Gilder - who predicted the iPhone 17 years early and gave Reagan the first microchip - is making his boldest call yet. He says an American nanotech "super-convergence" could mint more millionaires than any event in recent memory. He's found 3 stocks set to benefit before November 18's bombshell.
Study finds EVs quickly overcome their energy-intensive build to be cleaner than gas cars
DETROIT (AP) — Making electric vehicles and their batteries is a dirty process that uses a lot of energy. But a new study says that EVs quickly make up for that with through two years of use than a gas-powered vehicle.
Anavex Life Sciences' Alzheimer's Drug Candidate Shows Continued Long-Term Benefit Versus Control Group
Anavex reports sustained cognitive benefits from oral blarcamesine, showing slower Alzheimer's progression and long-term efficacy over 144 weeks.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.